Alerts will be sent to your verified email
Verify Email
SEQUENT
|
Viyash Scientific
|
Strides Pharma Scien
|
Procter&Gamble Healt
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.0 | 1.84 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
4.43 % | 30.1 % | 36.03 % |
|
5yr average Equity Multiplier
|
2.16 | 2.62 | 1.79 |
|
5yr Average Asset Turnover Ratio
|
0.95 | 0.6 | 0.77 |
|
5yr Avg Net Profit Margin
|
0.03 % | 12.9 % | 19.19 % |
|
Price to Book
|
10.25 | 3.0 | 12.92 |
|
P/E
|
108.0 | 16.17 | 27.27 |
|
5yr Avg Cash Conversion Cycle
|
49.09 Days | -51.45 Days | -155.74 Days |
|
Inventory Days
|
80.25 Days | 69.05 Days | 36.01 Days |
|
Days Receivable
|
79.76 Days | 60.35 Days | 40.92 Days |
|
Days Payable
|
114.46 Days | 225.58 Days | 215.28 Days |
|
5yr Average Interest Coverage Ratio
|
1.93 | 0.72 | 500.05 |
|
5yr Avg ROCE
|
6.67 % | 10.5 % | 30.21 % |
|
5yr Avg Operating Profit Margin
|
7.74 % | 12.17 % | 27.53 % |
|
5 yr average Debt to Equity
|
0.53 | 1.01 | 0.0 |
|
5yr CAGR Net Profit
|
-25.52 % | 68.01 % | 4.02 % |
|
5yr Average Return on Assets
|
0.05 % | 10.97 % | 15.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.41 % | 27.86 % | 51.82 % |
|
Share Pledged by Promoters
|
0.0 | 30.6 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
8.62 % | -3.03 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.57 % | -3.06 % | 3.2 % |
|
Viyash Scientific
|
Strides Pharma Scien
|
Procter&Gamble Healt
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Customer Segment
|
Customer Segment
|
Customer Segment
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|
|
R&D Break-Up - Product Wise
|
R&D Break-Up - Product Wise
|
-
|
-
|
|
Dosage Form Break-Up
|
Dosage Form Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
|
Species Break-Up
|
Species Break-Up
|
-
|
-
|